AP
ACUR

Atwood & Palmer’s Acura Pharmaceuticals ACUR Stock Holding History

Atwood & Palmer’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,010
Closed -$1K – 351
2016
Q4 		$1K Hold
1,010
– – ﹤0.01% 330
2016
Q3 		$2K Hold
1,010
– – ﹤0.01% 316
2016
Q2 		$2K Hold
1,010
– – ﹤0.01% 299
2016
Q1 		$3K Buy
+1,010
New +$2.15K ﹤0.01% 296
2014
Q3 		– Sell
-1,010
Closed -$6K – 399
2014
Q2 		$6K Buy
+1,010
New +$6.12K ﹤0.01% 291

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Atwood & Palmer's ACUR Position: Q1 2017 in Review

Atwood & Palmer sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 1,010 shares — an estimated $1K sold.

Atwood & Palmer first reported a position in ACUR in Q2 2014 and held it in 5 quarters. The position peaked at $6K in Q2 2014. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Atwood & Palmer reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Atwood & Palmer sold 1,010 Acura Pharmaceuticals shares in Q1 2017, an estimated $1K.
  • Atwood & Palmer first reported a position in Acura Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Atwood & Palmer's Acura Pharmaceuticals position peaked at $6K in Q2 2014.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Atwood & Palmer's 13F filing for Q1 2017, filed 28 Apr 2017.